Overview

Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Will metformin improve exercise capacity in chronic heart failure patients who has insulin resistance (pre-diabetic- means before they become diabetic)?
Phase:
Phase 4
Details
Lead Sponsor:
University of Dundee
Treatments:
Insulin
Metformin